CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy

Cancer Gene Ther. 2020 May;27(5):389-392. doi: 10.1038/s41417-019-0106-x. Epub 2019 May 27.

Authors

Zhenyu Jia¹, Jing Jia^#², Shuzhi Zhang^#¹, Jiang Cao³

Affiliations

¹ Institute of Occupational Diseases, Zhejiang Academy of Medical Sciences, Hangzhou, China.
² Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, China.
³ Clinical Research Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. caoj@zju.edu.cn.

^# Contributed equally.

PMID: 31130730
DOI: 10.1038/s41417-019-0106-x

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cytomegalovirus Infections*
Enhancer Elements, Genetic
Genes, Neoplasm
Humans
Neoplasms*
Promoter Regions, Genetic